Related Experiment Video
Updated: May 5, 2026

Co-immunoprecipitation of the Mouse Mx1 Protein with the Influenza A Virus Nucleoprotein
Published on: April 21, 2015
Lock out: targeting TMPRSS2 to block influenza and coronaviruses
Lu Zhang1,2, Markus Hoffmann1, Stefan Pöhlmann1,2
1Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany.
Abstract:
Coronaviruses and influenza A viruses (IAV) can cause severe respiratory disease and have pandemic potential. Both viruses depend on priming of their glycoproteins by host cell proteases for the acquisition of infectivity, and the responsible enzymes represent potential targets for intervention. Initial studies suggested that these viruses may exploit redundant proteolytic systems. However, research conducted over the last two decades has pointed to a key role for a single enzyme in coronavirus and IAV priming, the transmembrane protease serine 2 (TMPRSS2). Interest in TMPRSS2 as a host dependency factor and therapeutic target intensified during the COVID-19 pandemic, prompting extensive investigation into its biology, substrate specificity, and pharmacological inhibition. Here, we review recent efforts to define the role of TMPRSS2 in coronavirus infection and to target this protease for antiviral intervention.
Insights
Transmembrane protease serine 2 (TMPRSS2) is crucial for activating coronaviruses and influenza A viruses (IAV). Targeting TMPRSS2 offers a promising strategy for developing new antiviral therapies against these respiratory pathogens.
Area of Science:
- Virology
- Biochemistry
- Pharmacology
Background:
- Coronaviruses and influenza A viruses (IAV) cause severe respiratory illness with pandemic potential.
- Viral glycoprotein priming by host proteases is essential for infectivity, representing a key target for antiviral strategies.
Purpose of the Study:
- To review the critical role of transmembrane protease serine 2 (TMPRSS2) in coronavirus and IAV priming.
- To summarize recent advancements in understanding TMPRSS2 biology and its inhibition for therapeutic purposes.
Main Methods:
- Literature review of studies on TMPRSS2 function in viral infections.
- Analysis of research on the substrate specificity and pharmacological inhibition of TMPRSS2.
Main Results:
- TMPRSS2 plays a central role in priming both coronavirus and IAV glycoproteins.
- Extensive research, intensified by the COVID-19 pandemic, has elucidated TMPRSS2's function and potential as a therapeutic target.
Conclusions:
- TMPRSS2 is a significant host dependency factor for coronaviruses and IAV.
- Targeting TMPRSS2 presents a viable therapeutic avenue for combating infections caused by these viruses.
Related Concept Videos
Leaky Scanning
Inhibitors of Viral Protein Synthesis
Influenza
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

